Offer - Urjas Oil for just ₹ 1
Ropitor 0.25 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Parkinson's Disease, Restless Legs Syndrome. Other than this, Ropitor 0.25 Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Ropitor 0.25 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Ropitor 0.25 Tablet also has some side effects, the most common being Sleepiness, Weakness, Influenza like symptoms. Some other side effects of Ropitor 0.25 Tablet have been listed ahead. Usually, these side effects of Ropitor 0.25 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Ropitor 0.25 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. In addition, Ropitor 0.25 Tablet's effects on the liver, heart and kidney are discussed below in the Ropitor 0.25 Tablet related warnings section.
Ropitor 0.25 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Psychosis as it can result in adverse effects. Other contraindications of Ropitor 0.25 Tablet have been discussed in the sections ahead.
Drug reaction of Ropitor 0.25 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Ropitor 0.25 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Ropitor 0.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Ropitor 0.25 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Ropitor. It is best to stop taking Ropitor immediately and inform your doctor if you notice any discomfort.
Is the use of Ropitor 0.25 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Ropitor. So it is adviced to consult the doctor before using it.
What is the effect of Ropitor 0.25 Tablet on the Kidneys?
Ropitor may have mild side effects on the kidneys.
What is the effect of Ropitor 0.25 Tablet on the Liver?
Very few cases of side effects of Ropitor on the liver have been reported.
What is the effect of Ropitor 0.25 Tablet on the Heart?
Ropitor is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Ropitor 0.25 Tablet unless your doctor advises you to do so -
Is this Ropitor 0.25 Tablet habit forming or addictive?
Ropitor 0.25 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ropitor 0.25 Tablet can make you feel drowsy.
Is it safe?
Ropitor 0.25 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Ropitor 0.25 Tablet can treat mental disorders.
Interaction between Food and Ropitor 0.25 Tablet
Some foods when eaten with Ropitor 0.25 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Ropitor 0.25 Tablet
Consult your doctor before consuming alcohol while taking Ropitor 0.25 Tablet as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Requip (ropinirole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1114-1116
